Dobutamine pharmacokinetics and pharmacodynamics in normal children and adolescents

R. A. Berg, J. F. Padbury, R. L. Donnerstein, Scott E Klewer, J. J. Hutter

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Pharmacokinetic and pharmacodynamic data on adrenergic agents in children have revealed wide ranges of plasma clearance rates and hemodynamic responses in patients with critical illnesses or myocardial dysfunction. In order to more clearly elucidate the underlying pharmacologic processes, graded i.v. dobutamine infusions of 0.5, 2.5 and 5.0 μg/kg/min were sequentially administered to healthy children and adolescents. Plasma dobutamine concentrations and hemodynamic responses, including echocardiographic measures of systolic and diastolic function, were determined at each infusion rate. Pharmacodynamic data were evaluated by both threshold modeling and mean hemodynamic responses to each infusion rate. Mean plasma dobutamine clearance was 115 ± 63 ml/kg/min, with an intersubject variability greater than 5- fold. These data establish that the previously published wide variability in dobutamine clearance is not due simply to underlying disease states. Dobutamine clearance was linear over the dosage range evaluated. Dobutamine improved systolic function even at plasma concentrations attained with infusion rates as low as 1 to 2 μg/kg/min. The improved systolic function was at least partially due to inotropic effects. In addition, dobutamine improved diastolic function and reduced afterload. Chronotropic effects were observed in only two subjects and only at higher plasma concentrations than the other hemodynamic effects. Individualized threshold modeling effectively described the log-linear relationship between plasma dobutamine concentration and hemodynamic response beyond the threshold concentration.

Original languageEnglish (US)
Pages (from-to)1232-1238
Number of pages7
JournalJournal of Pharmacology and Experimental Therapeutics
Volume265
Issue number3
StatePublished - 1993

Fingerprint

Dobutamine
Pharmacokinetics
Hemodynamics
Critical Illness
Adrenergic Agents

ASJC Scopus subject areas

  • Pharmacology

Cite this

Dobutamine pharmacokinetics and pharmacodynamics in normal children and adolescents. / Berg, R. A.; Padbury, J. F.; Donnerstein, R. L.; Klewer, Scott E; Hutter, J. J.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 265, No. 3, 1993, p. 1232-1238.

Research output: Contribution to journalArticle

Berg, R. A. ; Padbury, J. F. ; Donnerstein, R. L. ; Klewer, Scott E ; Hutter, J. J. / Dobutamine pharmacokinetics and pharmacodynamics in normal children and adolescents. In: Journal of Pharmacology and Experimental Therapeutics. 1993 ; Vol. 265, No. 3. pp. 1232-1238.
@article{83f6d794cf164dbaab2881191aa90a2c,
title = "Dobutamine pharmacokinetics and pharmacodynamics in normal children and adolescents",
abstract = "Pharmacokinetic and pharmacodynamic data on adrenergic agents in children have revealed wide ranges of plasma clearance rates and hemodynamic responses in patients with critical illnesses or myocardial dysfunction. In order to more clearly elucidate the underlying pharmacologic processes, graded i.v. dobutamine infusions of 0.5, 2.5 and 5.0 μg/kg/min were sequentially administered to healthy children and adolescents. Plasma dobutamine concentrations and hemodynamic responses, including echocardiographic measures of systolic and diastolic function, were determined at each infusion rate. Pharmacodynamic data were evaluated by both threshold modeling and mean hemodynamic responses to each infusion rate. Mean plasma dobutamine clearance was 115 ± 63 ml/kg/min, with an intersubject variability greater than 5- fold. These data establish that the previously published wide variability in dobutamine clearance is not due simply to underlying disease states. Dobutamine clearance was linear over the dosage range evaluated. Dobutamine improved systolic function even at plasma concentrations attained with infusion rates as low as 1 to 2 μg/kg/min. The improved systolic function was at least partially due to inotropic effects. In addition, dobutamine improved diastolic function and reduced afterload. Chronotropic effects were observed in only two subjects and only at higher plasma concentrations than the other hemodynamic effects. Individualized threshold modeling effectively described the log-linear relationship between plasma dobutamine concentration and hemodynamic response beyond the threshold concentration.",
author = "Berg, {R. A.} and Padbury, {J. F.} and Donnerstein, {R. L.} and Klewer, {Scott E} and Hutter, {J. J.}",
year = "1993",
language = "English (US)",
volume = "265",
pages = "1232--1238",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "3",

}

TY - JOUR

T1 - Dobutamine pharmacokinetics and pharmacodynamics in normal children and adolescents

AU - Berg, R. A.

AU - Padbury, J. F.

AU - Donnerstein, R. L.

AU - Klewer, Scott E

AU - Hutter, J. J.

PY - 1993

Y1 - 1993

N2 - Pharmacokinetic and pharmacodynamic data on adrenergic agents in children have revealed wide ranges of plasma clearance rates and hemodynamic responses in patients with critical illnesses or myocardial dysfunction. In order to more clearly elucidate the underlying pharmacologic processes, graded i.v. dobutamine infusions of 0.5, 2.5 and 5.0 μg/kg/min were sequentially administered to healthy children and adolescents. Plasma dobutamine concentrations and hemodynamic responses, including echocardiographic measures of systolic and diastolic function, were determined at each infusion rate. Pharmacodynamic data were evaluated by both threshold modeling and mean hemodynamic responses to each infusion rate. Mean plasma dobutamine clearance was 115 ± 63 ml/kg/min, with an intersubject variability greater than 5- fold. These data establish that the previously published wide variability in dobutamine clearance is not due simply to underlying disease states. Dobutamine clearance was linear over the dosage range evaluated. Dobutamine improved systolic function even at plasma concentrations attained with infusion rates as low as 1 to 2 μg/kg/min. The improved systolic function was at least partially due to inotropic effects. In addition, dobutamine improved diastolic function and reduced afterload. Chronotropic effects were observed in only two subjects and only at higher plasma concentrations than the other hemodynamic effects. Individualized threshold modeling effectively described the log-linear relationship between plasma dobutamine concentration and hemodynamic response beyond the threshold concentration.

AB - Pharmacokinetic and pharmacodynamic data on adrenergic agents in children have revealed wide ranges of plasma clearance rates and hemodynamic responses in patients with critical illnesses or myocardial dysfunction. In order to more clearly elucidate the underlying pharmacologic processes, graded i.v. dobutamine infusions of 0.5, 2.5 and 5.0 μg/kg/min were sequentially administered to healthy children and adolescents. Plasma dobutamine concentrations and hemodynamic responses, including echocardiographic measures of systolic and diastolic function, were determined at each infusion rate. Pharmacodynamic data were evaluated by both threshold modeling and mean hemodynamic responses to each infusion rate. Mean plasma dobutamine clearance was 115 ± 63 ml/kg/min, with an intersubject variability greater than 5- fold. These data establish that the previously published wide variability in dobutamine clearance is not due simply to underlying disease states. Dobutamine clearance was linear over the dosage range evaluated. Dobutamine improved systolic function even at plasma concentrations attained with infusion rates as low as 1 to 2 μg/kg/min. The improved systolic function was at least partially due to inotropic effects. In addition, dobutamine improved diastolic function and reduced afterload. Chronotropic effects were observed in only two subjects and only at higher plasma concentrations than the other hemodynamic effects. Individualized threshold modeling effectively described the log-linear relationship between plasma dobutamine concentration and hemodynamic response beyond the threshold concentration.

UR - http://www.scopus.com/inward/record.url?scp=0027452071&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027452071&partnerID=8YFLogxK

M3 - Article

C2 - 8510005

AN - SCOPUS:0027452071

VL - 265

SP - 1232

EP - 1238

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 3

ER -